Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 96.94
(4.99%)
INR 96.94
(4.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 300.38 Million INR | 65.64% |
| 2022 | 135.17 Million INR | 33.3% |
| 2021 | 101.4 Million INR | 20.33% |
| 2020 | 84.26 Million INR | -4.73% |
| 2019 | 88.44 Million INR | 89.43% |
| 2018 | 46.69 Million INR | 7.93% |
| 2017 | 43.25 Million INR | 17.37% |
| 2016 | 36.85 Million INR | 22.22% |
| 2015 | 30.15 Million INR | 85.98% |
| 2014 | 16.21 Million INR | 44.38% |
| 2013 | 11.23 Million INR | -32.49% |
| 2012 | 16.63 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 31.61 Million INR | -66.49% |
| 2023 Q3 | 97.52 Million INR | 40.11% |
| 2023 FY | 223.89 Million INR | 65.64% |
| 2023 Q1 | 22.49 Million INR | -66.49% |
| 2023 Q2 | 69.6 Million INR | 209.37% |
| 2023 Q4 | 71.62 Million INR | -26.56% |
| 2022 Q1 | 25.55 Million INR | -9.72% |
| 2022 FY | 135.17 Million INR | 33.3% |
| 2022 Q2 | 22.23 Million INR | -12.98% |
| 2022 Q4 | 67.13 Million INR | 231.81% |
| 2022 Q3 | 20.23 Million INR | -9.02% |
| 2021 Q2 | -11.74 Million INR | -248.04% |
| 2021 Q4 | 28.31 Million INR | 151.96% |
| 2021 Q3 | 11.23 Million INR | 195.7% |
| 2021 Q1 | 7.93 Million INR | -72.33% |
| 2021 FY | 101.4 Million INR | 20.33% |
| 2020 Q4 | 28.66 Million INR | 13.94% |
| 2020 Q1 | 11.98 Million INR | -67.11% |
| 2020 FY | 84.26 Million INR | -4.73% |
| 2020 Q2 | 18.46 Million INR | 54.11% |
| 2020 Q3 | 25.15 Million INR | 36.23% |
| 2019 Q3 | 26.18 Million INR | 1135.58% |
| 2019 FY | 88.44 Million INR | 89.43% |
| 2019 Q1 | 9.71 Million INR | -45.05% |
| 2019 Q4 | 36.43 Million INR | 39.14% |
| 2019 Q2 | 2.11 Million INR | -78.19% |
| 2018 FY | 46.69 Million INR | 7.93% |
| 2018 Q4 | 17.68 Million INR | 66.83% |
| 2018 Q3 | 10.59 Million INR | 30.23% |
| 2018 Q2 | 8.13 Million INR | -20.79% |
| 2018 Q1 | 10.27 Million INR | 20.29% |
| 2017 Q1 | 7.55 Million INR | -57.21% |
| 2017 Q2 | 3.63 Million INR | -51.93% |
| 2017 Q3 | 24.82 Million INR | 583.43% |
| 2017 Q4 | 8.54 Million INR | -65.59% |
| 2017 FY | 43.25 Million INR | 17.37% |
| 2016 Q4 | 17.65 Million INR | 65.73% |
| 2016 FY | 36.85 Million INR | 22.22% |
| 2016 Q3 | 10.65 Million INR | 404.26% |
| 2016 Q2 | 2.11 Million INR | -66.92% |
| 2016 Q1 | 6.38 Million INR | -54.79% |
| 2015 FY | 30.15 Million INR | 85.98% |
| 2015 Q4 | 14.13 Million INR | 198.12% |
| 2015 Q3 | 4.74 Million INR | 727.23% |
| 2015 Q2 | 573 Thousand INR | -91.22% |
| 2015 Q1 | 6.52 Million INR | 10.67% |
| 2014 Q1 | 2.64 Million INR | -75.98% |
| 2014 Q3 | 3.09 Million INR | -58.95% |
| 2014 FY | 16.21 Million INR | 44.38% |
| 2014 Q4 | 5.89 Million INR | 90.68% |
| 2014 Q2 | 7.53 Million INR | 184.98% |
| 2013 Q3 | 1.57 Million INR | 3845.24% |
| 2013 Q2 | -42 Thousand INR | 94.76% |
| 2013 Q1 | -802 Thousand INR | -106.95% |
| 2013 FY | 11.23 Million INR | -32.49% |
| 2013 Q4 | 11 Million INR | 599.86% |
| 2012 Q3 | 4.44 Million INR | -8.54% |
| 2012 FY | 16.63 Million INR | 0.0% |
| 2012 Q2 | 4.85 Million INR | 263.27% |
| 2012 Q1 | -2.97 Million INR | 72.57% |
| 2012 Q4 | 11.53 Million INR | 159.52% |
| 2011 Q2 | 9.06 Million INR | 0.0% |
| 2011 Q3 | 3.67 Million INR | -59.5% |
| 2011 Q4 | -10.84 Million INR | -395.58% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 3.14 Million INR | -9465.696% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | -168.768% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | -170.689% |
| Vasundhara Rasayans Limited | 207.68 Million INR | -44.637% |
| Sunil Healthcare Limited | 247.86 Million INR | -21.189% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -1534.131% |
| MedPlus Health Services Limited | 12.33 Billion INR | 97.564% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 304.796% |
| Patidar Buildcon Limited | -26 Thousand INR | 1155430.769% |
| Roopa Industries Limited | 72.95 Million INR | -311.753% |
| Smruthi Organics Limited | 324.76 Million INR | 7.506% |
| Trident Lifeline Limited | 119.08 Million INR | -152.251% |
| PANJON LTD. | 33.77 Million INR | -789.268% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 512.516% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | -112.424% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 1786.614% |
| Anuh Pharma Limited | 1.6 Billion INR | 81.266% |
| Crestchem Limited | 51.53 Million INR | -482.848% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 4141.248% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 13.46% |
| Tyche Industries Limited | 290.84 Million INR | -3.28% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 58.551% |
| Trimurthi Limited | 1.95 Million INR | -15296.515% |
| Norris Medicines Limited | 29.36 Million INR | -923.032% |
| Zenlabs Ethica Limited | 147.75 Million INR | -103.301% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 32.305% |
| ANG Lifesciences India Limited | 232.73 Million INR | -29.069% |
| Parmax Pharma Limited | 99.31 Million INR | -202.451% |
| Veerhealth Care Limited | 49.57 Million INR | -505.935% |
| Deccan Health Care Limited | 221.57 Million INR | -35.571% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 16.967% |
| Makers Laboratories Limited | 308.54 Million INR | 2.645% |
| Lactose (India) Limited | 230.3 Million INR | -30.427% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 401.012% |
| Zenith Healthcare Limited | 46.17 Million INR | -550.552% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -43.81% |
| Bacil Pharma Limited | -19.95 Thousand INR | 1505794.236% |
| PRAVEG LIMITED | 266.99 Million INR | -12.507% |
| Denis Chem Lab Limited | 596.24 Million INR | 49.62% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 79.096% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 72.897% |
| Colinz Laboratories Limited | 16.35 Million INR | -1736.662% |
| Godavari Drugs Limited | 359.01 Million INR | 16.329% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 74086.7% |
| Zenotech Laboratories Limited | 337.19 Million INR | 10.917% |
| Panchsheel Organics Limited | 356.44 Million INR | 15.728% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 55.444% |
| Vivanza Biosciences Limited | 19.38 Million INR | -1449.42% |
| Phaarmasia Limited | 38.89 Million INR | -672.399% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 74.958% |
| Medi-Caps Limited | 68.09 Million INR | -341.147% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 9.342% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 76.572% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 58.142% |
| Mercury Laboratories Limited | 279.39 Million INR | -7.515% |
| Gennex Laboratories Limited | 276.99 Million INR | -8.445% |
| BDH Industries Limited | 175.55 Million INR | -71.106% |
| Coral Laboratories Limited | 332.39 Million INR | 9.629% |
| Concord Drugs Limited | 116.7 Million INR | -157.391% |
| Bharat Parenterals Limited | 989.46 Million INR | 69.642% |
| Beryl Drugs Limited | 108.5 Million INR | -176.846% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -2897.864% |
| Evoq Remedies Limited | 47.43 Million INR | -533.271% |
| Add-Shop E-Retail Limited | 224.09 Million INR | -34.043% |
| Transchem Limited | -8.96 Million INR | 3450.278% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -671.387% |
| Parnax Lab Limited | 552.1 Million INR | 45.593% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | -355.048% |
| Kerala Ayurveda Limited | 447.69 Million INR | 32.903% |
| Cian Healthcare Limited | 113.16 Million INR | -165.434% |
| Trinity League India Limited | 1.23 Million INR | -24281.981% |
| Syschem (India) Limited | 569.04 Million INR | 47.213% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 837.795% |
| Natural Capsules Limited | 557.1 Million INR | 46.08% |
| Auro Laboratories Limited | 249.39 Million INR | -20.448% |